Topics in Antiviral Medicine
SJR0.918
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.918 | Q1 | 81.6% | |
| 2024 | — | — | 0.916 | Q1 | 81.9% | |
| 2023 | — | — | 0.614 | Q2 | 71.7% | |
| 2022 | — | — | 0.778 | Q2 | 79.7% | |
| 2021 | — | — | 1.113 | Q1 | 88.7% | |
| 2020 | — | — | 0.935 | Q2 | 83.8% | |
| 2019 | — | — | 1.554 | Q1 | 93.1% | |
| 2018 | — | — | 1.323 | Q1 | 89.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
2161-5853
ISSN
2161-5861
region
Northern America
coverage
2011-2025